Zdrowie i gospodarka · 21/05/2010

FDA Transparency Initiative: Draft Proposals for Public Comment Regarding Disclosure Policies of the U.S. Food and Drug Administration

The U.S. Food and Drug Administration (FDA) is releasing draft proposals for public comment on its disclosure policies, aiming to expand information sharing while protecting trade secrets and patient data. The agency invites public input on the proposals and prioritization.